Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
Ranica, Bergamo, Italy
About Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Mario Negri Institute for Pharmacological Research
4
Clinical Trials at Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
During the past decade, Clinical Research Center for Rare Diseases "Aldo e Cele Daccò" conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes
2011-09-01
2015-07-01
Completed
112
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò""
#1 collaborator was "Agenzia Italiana del Farmaco" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
According to Clinical.Site data, the most researched conditions in "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"" are
"Diabetes" (2 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"" in a lesser frequency.
Clinical Trials Intervention Types at Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
Most popular intervention types in "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Benazepril" (2 trials), "Benazepril/Valsartan" (2 trials), "Valsartan" (2 trials), "Octreotide-LAR" (1 trials) and "Paricalcitol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
The vast majority of trials in "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"" are
4 trials for "All" genders.
Clinical Trials Status at Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"
Currently, there are NaN active trials in "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Clinical Research Center for Rare Diseases "Aldo e Cele Daccò",
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Research Center for Rare Diseases "Aldo e Cele Daccò", 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".